Ipamorelin 10mg – selective GH stimulator without side hormones

General information about Ipamorelin

This peptide helps the body release more of its own growth hormone, which can change how the body allocates energy and repairs tissues.

As an agonist of the ghrelin receptor (GHSR-1a) in the GH secretagogue signaling pathway, the molecule is classified as a synthetic pentapeptide growth hormone secretagogue, with central and peripheral action on the pituitary somatotropic axis. For general orientation in naming/class and historical context: Wikipedia: Ipamorelin.

Mechanism of action

Binding to GHSR-1a activates G-protein-coupled signaling (including intracellular calcium mobilization), which stimulates pulsatile secretion of GH and secondarily may affect IGF‑1.

Clinical/preclinical data

Scientific use

In the laboratory setting it is used to model growth hormone biology, receptor pharmacology (GHSR-1a), comparisons with other secretagogues and assessment of acute hormonal responses. In the clinical setting data are fragmented and the product should not be interpreted as a therapeutic without regulatory approval; a guide for regulatory principles: FDA.

Pharmacokinetics 

As a short peptide, rapid proteolytic degradation and a short systemic half-life are expected; this supports short exposures and frequent time points in acute tests, as well as control of matrix/proteases in in vitro systems.

Purity and formula

Ipamorelin from MyPeptid provides conditions for testing and laboratory studies, as it has a purity >99% (HPLC), suitable for analytical validation and comparative experiments between batches.

Formula: C38H49N9O9

For sale for educational and research purposes only!